CBD is everywhere—but how much do we really know about it? In this ultimate guide, Dr. Jeff Chen—physician, researcher, and ...

Harmony Biosciences has paused a mid-stage trial of ZYN002 in 22q11.2 deletion syndrome after the THC-free cannabinoid drug ...

Researchers in the U.S and other countries have been looking closely at how cannabis can be used as medicine. One study shows ...

New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabidiol Global Market Report 2023" - https://www.reportlinker ...

Cannabidiol, a non-intoxicating derivative from cannabis, has been shown to reduce seizures and autism-like behaviors in a mouse model of a genetic disorder, Dravet syndrome. Children with this ...

Harmony also touts late-stage asset EPX-100 (clemizole hydrochloride), which the biotech is running through a pair of phase 3 trials in Dravet syndrome and Lennox-Gastaut Syndrome— both rare forms of ...

Please provide your email address to receive an email when new articles are posted on . Survey responses reflected positive language and communication outcomes after cannabidiol use. Further ...

A new study involving 11 epilepsy centers across the United States shows that a drug made from a medical marijuana derivative can reduce seizures in children and young adults with epilepsy who don't ...

Cannabidiol may halve the severity of chronic anxiety symptoms and impairment in young people, an Orygen pilot study has shown Cannabidiol may be effective in halving the severity of symptoms and ...

In a preclinical model of acute pericarditis, cannabidiol was found to significantly reduce pericardial effusion and thickening. The Food and Drug Administration (FDA) has granted Orphan Drug ...

The appraisal committee considered evidence submitted by GW Pharma, a review of this submission by the evidence review group (ERG) and the technical report developed through engagement with ...